Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Behavioral Medicine
Published in: International Journal of Behavioral Medicine 2/2018

01-04-2018

Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease

Authors: Nagwa Essa, Sara Awad, Mariam Nashaat

Published in: International Journal of Behavioral Medicine | Issue 2/2018

Login to get access

Abstract

Purpose

To translate and cross-culturally adapt the Skindex-16, a brief skin-disease-specific QoL questionnaire, into Arabic for Egyptians and to evaluate its measurement properties in Egyptian patients with skin disease.

Method

Translation and cultural adaption were performed following guidelines for cross-cultural adaption of health-related quality of life measures. Subsequently, Skindex-16 was administered to 500 consecutive dermatological patients and 500 healthy persons for verification of its reliability and validity. Next, we examined the effect of skin disorders on QoL as well as influences of age, sex, socioeconomic level, education, and use of medication on skin disease-related QoL.

Results

The instrument showed high internal consistency reliability and good construct and content validity. The quality of life was most deteriorated in the emotional domain followed by symptoms domain (mean percentage score 55.5 ± 23.1 and 31.7 ± 26.8 respectively), while functioning was the least affected domain (mean percentage score 29.1 ± 26.8). Higher total Skindex-16 scores were observed for patients with psoriasis, urticaria, acne, and atopic dermatitis than those with vitiligo and alopecia areata. Educational level, social class, medication use, and family history influenced the impact of skin disease on overall QoL.

Conclusion

The adapted Egyptian Arabic version of Skindex-16 is valid and reliable; it showed that skin problems had a clinically significant impact on QoL in Egyptian patients.
Literature
1.
Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol. 1997;136:305–14.CrossRefPubMed
2.
Jayaprakasam A, Darvay A, Osborne G, McGibbon D. Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol. 2002;27(4):306–8.CrossRefPubMed
3.
Jones-Caballero M, Penas PF, Garcia-Diez A, Badia X, Chren MM. The Spanish version of Skindex-29: cultural adaptation and preliminary evidence of validity and equivalence with the original American version. Int J Dermatol. 2000;39:907–12.CrossRefPubMed
4.
Hill J, Bird HA, Lawton CW, Wright V. The arthritis impact measurement scales: an anglicized version to assess the outcome of British patients with rheumatoid arthritis. Br J Rheumatol. 1990;29:193–6.CrossRefPubMed
5.
Kleinman A, Eisenberg L, Good B. Culture, illness and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88:251–8.CrossRefPubMed
6.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. Clin Epidemiol. 1993;46:1417–32.CrossRef
7.
Chren MM, Lasek RJ, Quinn M, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707–13.CrossRefPubMed
8.
Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality of life instrument for patients with skin diseases. Arch Dermatol. 1997;133:1433–40.CrossRefPubMed
9.
Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30:231–6.CrossRefPubMed
10.
Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of skindex-16: a brief quality of life measure for patients with skin diseases. J Cutan Med Surg. 2001;5:105–10.CrossRefPubMed
11.
Comrey LA, Lee HB. A first course in factor analysis. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1992.
12.
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539–49.CrossRefPubMedPubMedCentral
13.
Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren MM. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. Dermatol. 2002;29:693–8.CrossRef
14.
15.
Hu L, Bentler PM. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol Methods. 1998;3:424–53.CrossRef
16.
Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6:1–55.CrossRef
17.
He Z, Lu C, Chren MM, Zhang Z, Li Y, Ni X, et al. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes. 2014;12:190.CrossRefPubMedPubMedCentral
18.
AlGhamdi KM, AlShammari SA. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity. Int J Dermatol. 2007;46:247–52.CrossRefPubMed
19.
Chua SL, Maurer T, Chren MM. Adaptation of a Runyankore version of Skindex-16 for oral administration in Mbarara. Uganda Int J Dermatol. 2011;50:1249–54.
20.
El Fakir S, Baybay H, Bendahhou K, Obtel M, Benchat L, Mernissi FZ, et al. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco. J Dermatol Treat. 2012;25:106–9.CrossRef
21.
Abolfotouh MA, Al-Khowailed MS, Suliman WE, Al-Turaif DA, Al-Bluwi E, Al-Kahtani HS. Quality of life in patients with skin diseases in central Saudi Arabia. Int J Genl Med. 2012;5:633–42.CrossRef
22.
Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80(6):430–4.CrossRefPubMed
23.
Zachariae R, Zachariae C, Ibsen HH, Wulf HC, Mortensen JT. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol. 2004;84:205–12.CrossRefPubMed
24.
Coghi S, Bortoletto MC, Sampaio SAP, De Andrade Junior HA, Aoki V. Quality of life is severely compromised in adult patients with atopic dermatitis in Brazil, especially due to mental components. Clinics. 2007;62:235–42.CrossRefPubMed
25.
Finlay AY, Khan GK. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.CrossRefPubMed
26.
Kosaraju SKM, Reddy SR, Vadlamani N, Sandhya L, Kalasapati L, Maganti S, et al. Psychological morbidity among dermatological patients in a rural setting. Int J Dermatol. 2015;60:635.
27.
Ghajarzadeh M, Ghiasi M, Kheirkhah S. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Acta Med Iran. 2012;50:511–5.PubMed
28.
Radtke MA, Schafer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161:134–9.CrossRefPubMed
29.
Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140(4):667–71.CrossRefPubMed
30.
Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134:454–8.CrossRefPubMed
31.
Grob JJ, Revuz J, Ortonne JP, Auguier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis, and atopic dermatitis on the QoL. Int J Dermatol. 2005;152:289–95.
32.
Chernyshov PV. Health related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity. G Ital Dermatol Venereol. 2014;151:37–43.PubMed
33.
Mayrshofer F, Herti M, Sinkgraven R, Sticherling M, Pfeiffer C, Zillikens D, et al. Significant decrease in quality of life in patients with pemphigus vulgaris, result from the German bullous skin disease (BSD) study group. J Dtsch Dermatol Ges. 2005;3:431–5.
34.
Paradisi A, Sampogna F, Di Pietro C, Cianchini G, Didora B, Ferri R, et al. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools. J Am Acad Dermatol. 2009;60(2):261–9.CrossRefPubMed
35.
Prinsen CA, Lindeboom R, Sprangers M, Legierse CM, De Korte J. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol. 2010;130:1318–22.CrossRefPubMed
36.
Gurel MS, Yanik M, Simsek Z, Kati M, Karaman A. Quality of life instrument for Turkish people with skin diseases. Int J Dermatol. 2005;44:933–8.CrossRefPubMed
37.
Tabolli S, Pagliarello C, Di Pietro C, Abeni D. Limited role of marital status in the impact of dermatological diseases on quality of life. Eur J Dermatol. 2012;22:672–7.PubMed
38.
39.
Al Robaee AA. Assessment of general health and quality of life in patients with acne using a validated generic questionnaire. Acta Dermatoven Alp Panonica Adriat. 2009;18:157–64.
40.
Leeyaphan C, Wanitphakdeedeche R, Manuskiatti W, Kulthanan K. Measuring melasma patients’ QoL using willingness to pay and time trade-off methods in thai population. BMC Dermatol. 2011;11:6.CrossRef
41.
Sampogna F, Spagnoli A, Di Pietro C, Pagliarello C, Paradis A, Tabolli S, et al. Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients. J Invest Dermatol. 2013;133:104–9.CrossRefPubMed
42.
Al Robaee AA. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province. Saudi Arabia Saudi Med J. 2007;28:1414–7.
43.
Szepietowski JC, Reich A, Wesolowska-Szepietowska E, Baran E. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and educational level. Mycoses. 2009;52:357–63.CrossRefPubMed
44.
Jobanputra R, Bachmann M. The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town. South Africa Int J Dermatol. 2000;39(11):826–31.
45.
Quandt SA, Schulz MR, Vallejos QM, Feldman SR, Verma A, Fleischer AB, et al. The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant farm workers. Int J Dermatol. 2008;47:236–41.CrossRefPubMed
Metadata
Title
Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease
Authors
Nagwa Essa
Sara Awad
Mariam Nashaat
Publication date
01-04-2018
Publisher
Springer US
Published in
International Journal of Behavioral Medicine / Issue 2/2018
Print ISSN: 1070-5503
Electronic ISSN: 1532-7558
DOI
https://doi.org/10.1007/s12529-017-9677-9

Other articles of this Issue 2/2018

International Journal of Behavioral Medicine 2/2018 Go to the issue

OriginalPaper

Perseverative Cognition as an Explanatory Mechanism in the Relation Between Job Demands and Sleep Quality

BriefCommunication

Sources of Variability in Physical Activity Among Inactive People with Multiple Sclerosis

OriginalPaper

Type D Personality and Sleep Quality in Coronary Artery Disease Patients With and Without Obstructive Sleep Apnea: Mediating Effects of Anxiety and Depression

OriginalPaper

The Epidemiology of Depressive Symptoms and Poor Sleep: Findings from the English Longitudinal Study of Ageing (ELSA)

Correction

Correction to: Mild Depression in Low Back Pain: the Interaction of Thought Suppression and Stress Plays a Role, Especially in Female Patients

OriginalPaper

The Pain of Ambivalence over Emotional Expression